Binarex Tablets

Binarex, PRESCRIPTION MEDICINE. The active ingredient in each Binarex tablet contains 50 mg bicalutamide. Binarex 50 mg is provided in packs of 28 tablets.

Binarex is indicated for the treatment of advanced prostate cancer in combination with GnRH luteinizing-hormone releasing hormone (LHRH) agonist therapy or surgical castration. Binarex is also indicated for the prevention of disease flare associated with the use of LHRH agonists.

Binarex tablets have risks and benefits. Do not use Binarex tablets if you are allergic to bicalutamide or any of the other ingredients of Binarex tablets. Discuss with your doctor if you are allergic to any dyes, preservatives, other medication or foods. Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, including any medicines obtained without a prescription from your pharmacy, health store or supermarket.

Binarex tablets are contraindicated in females and children. Binarex tablets must not be given to any patient who has shown a hypersensitivity reaction to the active substance or to any of the excipients. Bicalutamide is extensively metabolised in the liver. Data suggest that its elimination may be slower in subjects with severe hepatic impairment and this could lead to increased accumulation of bicalutamide. Therefore, Binarex tablets should be used with caution in patients with moderate to severe hepatic impairment.

Your doctor will inform you of the Binarex tablet dosage you will be required to take each day. Abide by all instructions given by your doctor carefully. If you experience any side effects, talk to your doctor or healthcare professional. Discuss with your doctor if you have any concerns.

Binarex tablets are fully funded. Standard doctor’s fees and pharmacy charges apply.

Distributed by REX Medical Ltd, Auckland, New Zealand.